Difesa Capital Management, LP Chimerix Inc Transaction History
Difesa Capital Management, LP
- $0
- Q4 2023
Shares
2 transactions
Others Institutions Holding CMRX
# of Institutions
80Shares Held
29.6MCall Options Held
18.9KPut Options Held
40.9K-
Monaco Asset Management Sam4.38MShares$3.59 Million1.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$3.56 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.26MShares$1.86 Million0.03% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$1.78 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$1.55 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $71.9M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...